Among some of the more severe mental disorders is Schizophrenia, which is characterized by serious changes to a person’s thoughts and behavior. The disorder is best known in popular culture by it’s psychotic symptoms, such as affected individuals hearing voices that are not there. Known as Auditory Verbal Hallucinations, these types of hallucinations are experienced by nearly 70% of those with the disorder, and can be absolutely terrifying for those that have them. Thus, many treatments for the disorder focus on the quieting of these voices, such as antipsychotic drugs. The causes of schizophrenia are generally not well understood, though it is commonly believed that an imbalance in dopamine may play a role amongst other things, such as damage to myelin sheaths being a potential cause.
In an attempt to further treatment, a research team at the University of Caen in France worked with schizophrenic patients to see if Transcranial Magnetic Stimulation (TMS) could lessen the voices being heard. TMS is a method used in neuroscience to temporarily alter brain function utilizing a strong magnetic field, and can be precisely tuned to a specific brain region using methods such MRI. The team gave 26 patients TMS treatment and 33 other patients a sham treatment, and tested them using the Auditory Hallucinations Rating Scale to keep track of the voices they were hearing. Those in treatment received 20 Hz high-frequency pulses for 2 sessions a day for 2 days. The team was able to target the treatment to a part of the left side of the brain in the temporal lobe. The article states that said area is associated with language, which is most likely Wernicke’s area. The patients were then re-evaluated after 2 weeks and 34.6% of those that had TMS showed more than a 30% decrease in auditory hallucinations, versus 9.1% in the control group. The article states that this is the first controlled trial to see whether or not TMS would be a useful treatment.
With this study comes the question of how this can be commercially applied as a treatment for schizophrenia, as the logistics are difficult given the nature of TMS. Similarly to this, TMS has been proven be promising in the treatment of depression. However, going to a doctor’s office for TMS twice daily for weeks on end is difficult for most people to accomplish.TMS is also something patients cannot do on their own unlike taking a pill once daily, as a very specific area of the brain has to be targeted and the machinery can be difficult to operate. A potential solution to this would be a mass produced portable device for TMS, but this has yet to be developed. For now, further research and development is needed to better mental illness treatment.
Sources:



